I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Akila Viswanathan, M.D., M.P.H., M.Sc.
Erin Michos, M.D., M.H.S.
Rebecca Gottesman, M.D., Ph.D.
Akila Viswanathan, M.D., M.P.H., is the executive vice chair for Johns Hopkins Radiation Oncology and Molecular Radiation Sciences, director of gynecologic radiation for Johns Hopkins Medicine, and professor of radiation oncology and molecular radiation sciences for the Johns Hopkins University School of Medicine. Dr. Viswanathan sees patients at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and The Johns Hopkins Hospital. She is board certified in radiation oncology by the American Board of Radiology.
Named one of America’s Top Doctors by Newsweek and a Super Doctor by the Washington Post magazine, Dr. Viswanathan has expertise with gynecologic cancers and their treatment, including uterine cancers and image-guided brachytherapy. She has developed numerous clinical innovations, such as intensity-modulated radiation therapy (IMRT) techniques for gynecologic cancer treatment, whole abdomen IMRT protocol, a new vaginal balloon applicator, a new magnetic resonance (MR) tracking catheter, MR-compatible stirrups and Clinical Trial Management System software for the Johns Hopkins Department of Radiation Oncology.
Dr. Viswanathan has held leadership positions in the American Brachytherapy Society and the American Society for Radiation Oncology, and serves on the committees of the Gynecologic Cancer InterGroup and the Gynecologic Cancer Steering Committee for the National Cancer Institute.
She has published more than 130 articles and chapters, with her primary research interests focused on gynecologic malignancies, uterine cancers and image-guided brachytherapy. Her publications on contouring guidelines for 3D image-guided gynecologic brachytherapy have set the international standard. Dr. Viswanathan is also involved with clinical trials using novel therapeutics to improve survival for patients at a high risk of death from disease. She has grant support from the National Cancer Institute for research on inflammation and endometrial cancer, as well as support from the National Institutes of Health to further research MR-guided gynecologic brachytherapy. She is on the editorial board of Gynecologic Oncology and Brachytherapy, and is an editor of the text Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management.
Dr. Viswanathan earned her medical degree at the University of Pittsburgh School of Medicine, followed by her master’s degree in public health and master’s degree in epidemiology at the Harvard School of Public Health.
Erin Michos is an associate professor of medicine within the Division of Cardiology at the Johns Hopkins University School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the associate director of preventive cardiology with the Ciccarone Center for the Prevention of Heart Disease at Johns Hopkins. She is a fellow of the American College of Cardiology and a fellow of the American Heart Association.
Her research interests are in the areas of preventive cardiology and cardiovascular epidemiology, with particular focus on (1) physical activity and nutrition; (2) risk prediction for cardiovascular disease including the use of coronary artery calcium scores and biomarkers, (3) lipids and statin therapy, (4) cardiovascular disease among women and (4) vitamin D.
As part of the Johns Hopkins cardiology faculty, her clinical duties entail seeing patients in the preventive cardiology outpatient clinic and the echocardiography lab. She also teaches students at the Johns Hopkins University School of Medicine and the Bloomberg School of Public Health. She is the chair of the Women’s Task Force for the Cardiology Division at Johns Hopkins. She is part of the editorial board for the journal Circulation.
Dr. Michos is the recipient of independent investigator funding through the National Institutes of Health (NIH) RO1 mechanism. She is a co-investigator in the NIH-funded Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities studies. She is an investigator in an ongoing NIH-funded clinical trial studying vitamin D and fall prevention, called the STURDY trial. She is the training director for the AHA fellowship program for the AHA’s Go Red for Women Strategic Focus Research Network at Johns Hopkins for research in women’s cardiovascular health.
Dr. Michos completed medical school at Northwestern University in Chicago, Illinois. She also completed her master’s degree in health science in cardiovascular epidemiology at the Johns Hopkins Bloomberg School of Public Health.
Rebecca Gottesman is a professor of neurology, with a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health, and is a core faculty member of the Welch Center for Prevention, Epidemiology, and Clinical Research. Her primary clinical interest is stroke.
Her primary research interests include the vascular contribution to cognitive impairment and dementia, with evaluation not only of stroke as a potential risk factor for cognitive change but also vascular risk factors such as hypertension. She works primarily with the Atherosclerosis Risk in Communities study in order to evaluate these long-term associations between vascular risk factors and vascular disease, each, and cognition, using epidemiology and neuroimaging methods. She runs the SCAN lab (Stroke and Cognitive impairment Analysis using Neuroepidemiology) to pursue these research interests.
Dr. Gottesman received her medical degree from the Columbia College of Physicians and Surgeons in New York. She completed her internship in internal medicine at Johns Hopkins Bayview Medical Center, and her neurology residency at The Johns Hopkins Hospital in Baltimore, Maryland. She completed a stroke fellowship and received a doctorate in the Graduate Training Program in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health.